| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/08/2005 | CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids |
| 06/08/2005 | CN1205175C Application of amine derivative in medicine prepared with the function of anti-pulmonary hypertension |
| 06/08/2005 | CN1204910C Medicine for treating arteriosclerosis |
| 06/08/2005 | CN1204896C Preparation method and use of ribonucleic acid injection |
| 06/08/2005 | CN1204889C Adhesion receptor antagonists |
| 06/08/2005 | CN1204885C Pharmaceutical composition contg. fenofibrate and preparation method |
| 06/08/2005 | CN1204884C N-acetyl-L cysteine for preparing medicine for treating epithelial tumous |
| 06/07/2005 | US6903244 For screening drugs for treatment of atherosclerosis and hypertension |
| 06/07/2005 | US6903216 Antiarrhythmic agents for the treatment and prophylaxis of atrial arrhythmias, atrial fibrillation (AF) or atrial flutter; potassium channel modulators, beta-blocker |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903188 Isolated functional derivative of an Mts protein that is preferably a multimeric protein complex. |
| 06/07/2005 | US6903186 Analogues of GLP-1 |
| 06/07/2005 | US6903137 Agonists specific for the peripheral cannabinoid receptor |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903130 (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide stereoisomer for the treatment of bipolar disorders |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903127 Sexual disorders |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903107 Serine protease inhibitor |
| 06/07/2005 | US6903103 Linear cyclic ureas |
| 06/07/2005 | US6903099 Heterocyclic amides used as preferential inhibitors of cyclic guanosine 3',5'-monophosphate specific phosphodiesterase, for prophylaxis of cardiovascular disorders and erectile dysfunction |
| 06/07/2005 | US6903098 Use of phthalazine derivatives |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6903089 Lactam-substituted pyrazolopyridine derivatives |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 06/07/2005 | US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
| 06/07/2005 | US6903085 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/07/2005 | US6902885 For detecting viral and cellular polypeptide interactions |
| 06/07/2005 | CA2348026C Antibodies against semp1, methods for their production and uses thereof |
| 06/07/2005 | CA2332686C Novel 13 and 14-membered antibacterial and prokinetic macrolides and their intermediates |
| 06/07/2005 | CA2299036C 4-phenyl-4-heteroarylpiperidine derivatives |
| 06/07/2005 | CA2281090C Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
| 06/07/2005 | CA2074853C 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents |
| 06/07/2005 | CA2051693C Allosteric hemoglobin modifiers |
| 06/02/2005 | WO2005049058A1 Radix salviae miltiorrhizae, extract and composition thereof for the treatment of the aspirin resistance diseases |
| 06/02/2005 | WO2005049046A1 Hypotensive drug and process for producing the same |
| 06/02/2005 | WO2005037197A3 Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/02/2005 | WO2005034929A9 Tissue remodeling and vascularization |
| 06/02/2005 | WO2005030332A3 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 06/02/2005 | WO2005013884A3 Methods for preventing neurological events |
| 06/02/2005 | WO2005007845A3 Transgenic cells |
| 06/02/2005 | WO2004093797A3 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 06/02/2005 | WO2003075847A3 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS |
| 06/02/2005 | WO2003059253A3 Compositions and methods for altering glucose production |
| 06/02/2005 | US20050119499 Cyclic hemiacetal derivative and use thereof |
| 06/02/2005 | US20050119492 Industrial scale acylation of 2-[1-(ethoxycarbonyl)butylamino]propionic acid with a carbonic acid derivative, activation with thionyl chloride, amidation with octahydroindol-2(S)-carboxylic acid, salt formation with tert-butylamine; hypotensive agents; angiotensin I-converting enzyme (ACE) inhibitor |
| 06/02/2005 | US20050119486 Diamine derivatives |
| 06/02/2005 | US20050119458 Transport protein for use in identifying modulator for prevention and treatment of cell proliferative, skin and psychological disorders; anticonvulsants; insecticides; pesticides; anthelmintics |
| 06/02/2005 | US20050119450 Biodegradable polyphosphoramidates for controlled release of bioactive substances |
| 06/02/2005 | US20050119343 Crystalline form; inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase; for oral administration |
| 06/02/2005 | US20050119334 Neurodegenerative disease; Alzheimer's and Parkinson's disease |
| 06/02/2005 | US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor |
| 06/02/2005 | US20050119327 1-benzyl-5-[(3-methylphenyl)amino]-3-phenyl-1H-indole-2-carboxylic acid; plasminogen activator inhibitor (PAI-1) inhibitor; fibrinolytic system disorder; atrial fibrillation, pulmonary and renal fibrosis, Alzheimer's disease; anticarcinogenic, antiischemic, anticoagulant, antidiabetic |
| 06/02/2005 | US20050119320 5-phenylthiazole derivatives and use as pi3 kinase inhibitors |
| 06/02/2005 | US20050119316 Semicarbazide derivatives and the use thereof as antithrombotics |
| 06/02/2005 | US20050119304 N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-(1H-indazol-5-yl)urea; vanilloid receptor (VR1) antagonist; blockage of neurotransmitter release |
| 06/02/2005 | US20050119297 Use of 5HT3 agonists for relaxing the fundus |
| 06/02/2005 | US20050119296 6-(1-benzofuran-2-yl)-2-(trifluoromethyl)quinolin-4-yl 1H-tetraazol-5-ylmethylether; plasminogen activator inhibitor; impairment of fibrinolytic system; cystic fibrosis, diabetes, chronic periodontitis, lymphomas; increased uPA levels (breast and ovarian cancer) |
| 06/02/2005 | US20050119291 Pyrimidine compounds |
| 06/02/2005 | US20050119280 1-[alkyl 1-[heteroaryl )alkyl] and 1-[ aryl) alkyl]-7-( pyrimidin-4-yl) imadazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 06/02/2005 | US20050119277 Benzazole derivatives for the treatment of scleroderma |
| 06/02/2005 | US20050119271 Pyrimidine A2B selective antagonist compounds, their synthesis and use |
| 06/02/2005 | US20050119267 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 06/02/2005 | US20050119259 Synergistic mixture of anticoagulant and antiarrhythmia agents |
| 06/02/2005 | US20050119250 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2005 | US20050119246 2-(4-{[1-(2,2-dimethylpropanoyl)-4-piperidinyl]methyl}-3,5-dimethyl-1H-pyrazol-1-yl)-1-methylethylcarbamate; appetite suppressants; obesity, diabetes, feeding behavior, bulimia, anorexia nervosa and premenstrual tension; side effect reduction |
| 06/02/2005 | US20050119213 Vascular therapeutics |
| 06/02/2005 | US20050119206 Cg8327, cg10823, cg18418, cg15862, cg3768, cg11447 and cg16750 homologous proteins involved in the regulation of energy homeostasis |
| 06/02/2005 | US20050119190 Anticoagulants; cardiovascular disorders; thrombosis |
| 06/02/2005 | US20050119173 Novel potassium-dependent sodium-calcium exchanger |
| 06/02/2005 | US20050119165 Vascular endothelial growth factor dimers |
| 06/02/2005 | US20050119159 Remedy for ischemic heart failure |
| 06/02/2005 | US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/02/2005 | US20050118579 Using allelic variation in canalicular multispecific organic anion transporter (cMOAT) gene as diagnostic tool in detection of liver and bile duct disorders |
| 06/02/2005 | US20050118562 Methods for minimizing spasticity in blood vessel grafts |
| 06/02/2005 | US20050118290 Compositions and method for treatment of steroid/nuclear receptor-mediated diseases |
| 06/02/2005 | US20050118288 Method for producing high-quality hydropbic licorice extract |
| 06/02/2005 | US20050118259 stabilized by use of excipients comprising a basic compound, preferably an alkali-oralkaline earth metal carbonate, and an insoluble alkaline-earth metal carbonate, and an insoluble alkaline-earth metal hydrogen phosphate |
| 06/02/2005 | US20050118242 Using testosterone; topical applying to skins |
| 06/02/2005 | US20050118190 Staphylococcus antigen and vaccine |
| 06/02/2005 | US20050118178 Use of t-cell immune response cdna7 (tirc7) in angiogenic and anti-angiogenic therapy |
| 06/02/2005 | US20050118157 Treatment of central nervous system damage |
| 06/02/2005 | DE10352602A1 Kosmetisches oder therapeutisches Kombinationspräparat Cosmetic or therapeutic combination product |
| 06/02/2005 | CA2546227A1 Methods of preparing a foam comprising a sclerosing agent |
| 06/02/2005 | CA2546108A1 Methods of preparing a foam comprising a sclerosing agent |
| 06/02/2005 | CA2545944A1 Inhibition of trp channels as a treatment for cardiac hypertrophy and heart failure |
| 06/02/2005 | CA2545641A1 Use of organic compounds |
| 06/02/2005 | CA2545514A1 Combination of a dpp iv inhibitor and an antiobesity or appetite regulating agent |
| 06/02/2005 | CA2545196A1 Pyrazolopyrimidines |
| 06/02/2005 | CA2545049A1 Method for proliferating cardiomyocytes |
| 06/02/2005 | CA2544573A1 Combinations useful for the treatment of neuronal disorders |
| 06/02/2005 | CA2544230A1 Combinations of at1-antagonists, amiloride or triamterine, and a diuretic |
| 06/02/2005 | CA2537300A1 Treatment of asprin resistance with radix salviae miltiorrhizae, its extract and composition |
| 06/01/2005 | EP1536000A1 Method of judging inflammatory disease |
| 06/01/2005 | EP1535920A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 06/01/2005 | EP1535915A1 Furan or thiophene derivative and medicinal use thereof |
| 06/01/2005 | EP1535913A1 Novel quaternary ammonium compounds |
| 06/01/2005 | EP1535909A2 Cyclic amine derivatives and their use as drugs |